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Abstract In the presented study, we attempt to investigate if
the sensitization to conditioned place preference (CPP) in-
duced by low doses of morphine was developed in rats which
have been previously conditioned with morphine. The exper-
iments were performed in the CPP test. Firstly, it has been
demonstrated that administration of ineffective dose of mor-
phine on the 9th day induces the increase in time spent of rats
at a morphine-paired compartment, confirming that sensitiza-
tion to CPP has been developed in these animals. Secondly, it
has been shown that stimulation of A1 receptor significantly
inhibits the expression of morphine-induced of sensitization,
and blockade of these receptors produces the opposite effect.
Finally, it has been indicated that both stimulation and block-
ade of A1 and/or A2A receptors inhibit the acquisition of sen-
sitization to CPP. The obtained results have strongly supported
the significance of adenosinergic system in both expression
and acquisition of studied sensitization. These results seem to
be important for the identification of connections in the central
nervous system which can help finding new strategies to at-
tenuate rewarding action of morphine.
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Introduction
Adenosine, a potent inhibitory neuromodulator in the central
nervous system, acts via four most recognized adenosine re-
ceptor subtypes: A1, A2A, A2B, and A3. A1 receptors are high-
ly expressed in different brain areas, such as the cortex, the
cerebellum, the hippocampus, and dorsal horn of the spinal
cord. The distribution of A2A receptors is more limited and
found mainly in the striatopallidal γ-aminobutyric acid
(GABA)ergic neurons and in the olfactory bulb, while in other
brain areas, the receptors are expressed at lower levels (Ferré
et al. 1997). As a neuromodulator of the central nervous sys-
tem, adenosine may influence different processes, like sleep,
cognition, pain, etc. Many experimental data also confirm
adenosine participation in the state of dependence. As litera-
ture data have already shown, the significance of adenosine
receptors has repeatedly been demonstrated in various models
of behavioral sensitization, expressed by locomotor responses.
For example, a stimulation of A2A receptors significantly
inhibited both the expression and acquisition of cocaine-
induced sensitization in rats (Filip et al. 2006). the expression
of cocaine-induced sensitization was also inhibited after stim-
ulation of A1 or A2A receptors in the nucleus accumbens of
rats (Hobson et al. 2012). Additionally, Shimazoe et al. (2000)
have shown the importance of A1 and A2A receptors in both
the expression and acquisition of methamphetamine-induced
sensitization in rats. Similarly, in our previous study, an in-
volvement of adenosine A1 and/or A2A receptors was demon-
strated in the acquisition of morphine-induced behavioral sen-
sitization to the locomotor activity in mice (Listos et al. 2011).
Behavioral sensitization is defined as long-lasting and pro-
gressive enhancement of the locomotor and motivational re-
sponses to psychostimulants, following their repeated and in-
termittent administration. The sensitized animals begin to de-
velop addiction-like symptoms, including continued drug-
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seeking behavior and escalated drug intake, an increased mo-
tivation to find or receive drugs and a greater propensity to
relapse after enforced abstinence (Robinson and Berridge
2008). This phenomenon plays an important role in the etiol-
ogy and maintenance of drug-seeking behavior, as well as in
relapse to drug use, even after long-term abstinence periods
(Robinson and Berridge 1993, 2000; Stewart and Badiani
1993). Behavioral sensitization is the subject of numerous
investigations, attempted to identify drug relapse mechanisms
and design new therapeutic strategies, effective in drug addic-
tion treatment. Sensitization can be estimated in various ani-
mal models, mainly in the locomotor activity test (Harris et al.
2014; Listos et al. 2011; Martinez et al. 2014). In this para-
digm, the administration of a psychoactive drug in a low dose
(the priming dose) after a few days of interruption in the drug
use significantly intensifies the locomotor activity of animals,
confirming that drug-seeking behaviors have been developed.
Although studies on behavioral sensitization are focused on
increased locomotor activity of animals, a growing body of
evidence shows that sensitization may be developed to other
types of influence. For example, hyperalgesia (Ahmadi et al.
2014) or higher sensitivity to morphine-induced place prefer-
ence (Sahraei et al. 2007) was observed in morphine-
sensitized mice. Other authors also demonstrated in the con-
ditioned place preference (CPP) paradigm that a previous ex-
posure to morphine produced enhanced rewarding effects af-
ter morphine intake (Lett 1989; Manzanedo et al. 2005;
Shippenberg et al 1998). Additionally, Manzanedo et al.
(2005) demonstrated some involvement of dopaminergic sys-
tem in this phenomenon. Thus, although most studies on be-
havioral sensitization in animals are concentrated on their in-
creased locomotor activity, it seems both important and inter-
esting to extend our knowledge on sensitization to other
effects.
Therefore, in the presented study, we attempt to inves-
tigate if sensitization to conditioned place preference
(CPP), induced by low doses of morphine, was developed
in rats which had previously been conditioned with mor-
phine. The experiments were performed in the CPP test.
This test consists of three phases: pre-conditioning, con-
ditioning, and post-conditioning, and is generally accept-
ed in preclinical studies for assessment of the rewarding
properties of various abused drugs (Huston et al. 2013;
Lett 1989; Manzanedo et al. 2005; Shippenberg et al
1998). In order to develop sensitization to CPP, after the
post-conditioning stage, four test-free days followed, and
on the 9th day of the experiment, the post-conditioning
stage with the priming dose of morphine was carried out
afresh. Furthermore, effects of adenosine A1 and A2A li-
gands on the expression and acquisition of morphine-
induced sensitization to CPP in rats were studied in the
presented study. Regarding the expression, acute effects
of adenosine ligands were studied in morphine-induced
sensitization to CPP, while in acquisition, the significance
of longer exposure (three injections) of adenosinergic
agents was investigated during the development of behav-
ioral sensitization. In our previous study (Listos et al.
2011). we showed that adenosine agonists significantly
attenuated morphine-induced sensitization to the locomo-
tor activity of mice, which reflected morphine-seeking
behavior. In another study, we demonstrated that adeno-
sine agonists (2-p-(2-carboxyethyl)phenethylamino-5′-N-
ethylcarboxamidoadenosine hydrochloride (CGS 21680)
and 5′-N-ethylcarboxamidoadenosine (NECA)) were able
to inhibit the development of hypersensitivity to acute
dose of morphine given during morphine withdrawal pe-
riod (Listos et al. 2008). which also reflected morphine-
seeking behavior. Now, we present experiments which
show the role of both adenosine agonists and antagonists,
in sensitization to CPP, which reflect the sensitization to
rewarding action of morphine. As it has been mentioned,
the adenosinergic system plays an important role in dif-
ferent aspects of behavioral sensitization; thus, it is worth




The experiments were carried out on male Wistar rats (250–
300 g). The animals were kept at room temperature of 22±
1 °C, on natural day–night cycle. Standard food (Murigran
pellets, Bacutil, Motycz) and tap water were freely available.
All the experiments were made between 9 a.m. and 3 p.m.
After one week of adaptation and handling, the animals were
divided into groups (9–10 animals/group) and prepared for the
tests.
The study was performed according to the National
Institute of Health Guidelines for the Care and Use of
Laboratory Animals and the European Community
Council Directive for Care and Use of Laboratory
Animals and was approved by local ethics committee
(the Medical University of Lublin Committee on the Use
and Care of Animals, No. 45/2007).
Drugs
The following drugs were used in the experiments: mor-
phine hydrochloride (Polfa, Kutno, Poland) and adeno-
sine receptor ligands: N6-cyclopentyladenosine (CPA)—
the selective adenosine A1 receptor agonist; 2-p-(2-
c a r b o x y e t h y l ) p h e n e t h y l a m i n o - 5 ′ - N -
ethylcarboxamidoadenosine hydrochloride (CGS
21680)—the selective adenosine A2A receptor agonist;
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5′-N-ethylcarboxamidoadenosine (NECA)—the non-
selective adenosine A1/A2A receptor agonist with low
affinity for A2B and A3 receptors; 8-cyclopentyl-1,3-
dipropylxanthine (DPCPX)––the adenosine A1 receptor
antagonist with low affinity for A2B receptors; 2-(2-
furanyl)–7-(2-phenylethyl)-7H-pyrazolo(4,3-e)(1,2,
4)triazolo(1,5-c)pyrimidin-5-amine (SCH 58261)—the
selective adenosine A2A receptor antagonist—(all from
Sigma-Aldrich, St. Louis, USA), and caffeine—the non-
selective adenosine A1/A2A receptor antagonist (Polfa,
Kutno, Poland).
CPA, CGS 21680, caffeine, and morphine were dissolved
in saline; NECA, DPCPX, and SCH 58261 were dissolved in
minimal volume of DMSO (final concentration 0.1 %); and
then they were diluted in saline.
All drugs were given intraperitoneally (ip) in a volume of
10.0 ml/kg.
The following doses of drugs were used in the experiments:
morphine: 5.0 mg/kg—for conditioning or 0.5 and 0.75 mg/kg
as a priming dose for sensitization, CPA: 0.05 and 0.1 mg/kg,
CGS 21680: 0.025 and 0.05 mg/kg, NECA: 0.0005 and
0.001 mg/kg, DPCPX: 1.0 and 2.0 mg/kg, SCH 58261: 0.5
and 1.0 mg/kg, and caffeine: 5.0 and 10.0 mg/kg. The control
group animals received the same volume of saline at the re-
spective time before the test.
Apparatus and procedure
In all experiments, the CPP apparatus was used. The applied
equipment consisted of eight rectangular boxes (60×35×
30 cm), each of them divided into three compartments (25×
30 cm), separated by removable guillotine doors from a small
central gray area (10×10 cm). The walls of the two large
compartments differed in color (black floors and walls in
one compartment and white floors and walls in the other
one). The boxes were kept in a soundproof room with a neu-
tral masking noise and with a dim 40 lx illumination. The
animal behavior was observed on a monitor, displaying im-
ages from a digital video camera system, while the time pe-
riods, spent by rats in each compartment, were recorded by
means of video tracking software (Karnet, Lublin, Poland).
The procedure of the experiments was based on the proto-
col, described by Sahraei et al. (2007). that consisted of three,
typical for CPP paradigm, phases: pre-conditioning, condi-
tioning, and post-conditioning. Four days after the post-
conditioning phase (it means, five days after discontinuation
of morphine treatment), the induction of sensitization to the
CPP in rats was performed.
Pre-conditioning (the 1st day): This day, each rat was
placed separately into the central gray area for 15 min
(900 s) and left with free access to all the compartments.
The time period spent by each animal in the two large com-
partments was measured and recorded.
Conditioning (the 2nd–4th day): That phase consisted of a
3-day schedule of conditioning sessions. Each day, two ses-
sions were performed. During the first session, the rats re-
ceived saline and were placed in the preferred (black) com-
partment—morning sessions—for 30 min. Next, the rats re-
ceived morphine (5.0 mg/kg) and were placed in the
unpreferred compartment for the same period of time—after-
noon sessions. The intervals between saline and morphine
injections were at least 6 h. The procedure was repeated on
the 2nd and the 3rd days of conditioning.
Post-conditioning (the 5th day): On the 5th day (the pref-
erence test day), similar to the pre-conditioning phase, the
animals were placed into the central gray area for 15 min
(900 s), and the time period spent in the morphine-paired
compartment was recorded for each animal. No injections
were given on that day.
Induction of sensitization (the 9th day) to CPP in pre-
viously morphine-conditioned rats: On the 9th day of the
experiment (four days after the post-conditioning=five
days after the last morphine injection) to induce sensitiza-
tion to CPP, an ineffective dose of morphine (0.5 or
0.75 mg/kg)—the priming dose—was injected, and then,
the post-conditioning paradigm was performed once
again.
Effects of the adenosinergic system on sensitization to
CPP induced by priming dose of morphine: In order to
evaluate the influence of adenosine receptors on the ex-
pression of sensitization to CPP, on the 9th day of the
experiment, adenosine agonists or antagonists were ad-
ministered 20 min before the ineffective dose of mor-
phine. In order to assess the effect of adenosine ligands
on the acquisition of sensitization to CPP, all the adeno-
sine drugs were injected three times on the 2nd–4th day,
20 min before each morphine injection (5.0 mg/kg). The
method of administration of adenosine ligands is shown
in Scheme 1.
Statistical analysis
The obtained data are presented in the figures as the mean
values±S.E.M of scores. Score is a difference in the time
period [s] which the rats spent at a morphine-paired com-
partment. It was calculated according to the following
formula:
(a) for evaluation of behavioral sensitization: time period at
the morphine-paired compartment on the 9th day minus
the time period at the morphine-paired compartment on
the 1st day, and
(b) for evaluation of conditioning: time period at the
morphine-paired compartment on the 5th day minus
time period at the morphine-paired compartment on the
1st day.
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The locomotor activity of individual rats was measured as
the total distance, traveled during 15-min (900 s) period.
All the results were statistically calculated using the Graph
Pad Prism Software Package (version 5.04).
The two-way ANOVAwas used for the effects of morphine
and of the priming dose of morphine in the CPP test (Fig. 1.).
One-way ANOVA was applied for the effects of adenosine
drugs in morphine sensitization (Figs. 2 and 3.) and for statis-
tical analysis of the locomotor activity of rats (Table 1). Post
hoc comparisons were carried out by means of the Tukey test.
The probability (p) value of 0.05 or less was considered as
statistically significant. Each group of animals consisted of 9–
10 rats.
Results
Effects of morphine and adenosine ligands on locomotor
activity of rats (Table 1)
There were not observed any alterations in locomotor activity
of rats after administration of all doses of morphine, adenosine
ligands, and their combination.
Effects of morphine and priming dose of morphine in CPP
test on rats (Fig. 1.)
Two-way ANOVA demonstrated some changes in behav-
ior of the morphine preferring rats after the administra-
tion of the priming dose of morphine (0.5 and 0.75
mg/kg). After the application of morphine in dose of
0.75 mg/kg, a significant effect of drug (F1,32=19.32,
p=0.0001), day (F1,32=6.993, p=0.0126), and interac-
tion (F1,32=2,37 p=0.0363) was observed in animals.
An injection of morphine at a dose of 0.5 mg/kg as the
priming dose induced a significant effect of the drug (F1,
32=12.63, p=0.0012) but not of the day (F1,32=3.407,
p=0.0742) and interaction (F1,32=0.241, p=0.6268).
In the post hoc test, we demonstrated that an admin-
istration of morphine (5.0 mg/kg, ip) caused a significant
increase in the time spent at the morphine-paired com-
partment, in comparison with saline administration
(p<0.01). A significant increase was also observed in
the conditioning score after application of morphine in
dose of 0.75 mg/kg as the priming dose—p<0.01 in
compared with saline challenged rats, but no significant
changes were observed after the injection of 0.5 mg/kg
of morphine as the priming dose. Based on those data,
the dose of 0.5 mg/kg was selected as an ineffective dose
for remaining experiments. In subsequent experiments, a
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Scheme 1 The method of
administration of adenosine
ligands in expression and
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Fig. 1 Influence of ineffective morphine doses on morphine-conditioned
rats (5 mg/kg, ip). In order to morphine-induce sensitization to CPP, its
ineffective doses (0.5 and 0.75 mg/kg, ip) were administered on 9th day.
Results are expressed as mean±S.E.M of scores (n=9–10 rats/group).
Two-way ANOVA showed significant changes in the time spent at the
morphine-paired compartment. **p<0.01 (Tukey test)
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Effects of adenosine ligands on the expression
of sensitization to CPP in previously conditioned rats
(Fig. 2.)
One-wayANOVAdemonstrated that significant changes were
observed only after the administration of adenosine A1 recep-
tor ligands: agonist—CPA (F2,31=8.377, p=0.0013) and an-
tagonist—DPCPX (F2,32=5.009, p=0.0133). Insignificant
changes were evaluated after the administration of adenosine
A2A receptor ligands: agonist—CGS 21680 (F2,29=1.858,
p=0.1755) and antagonist—SCH (F2,30=2.82, p=0.766) or
non-selective A1/A2A ligands: agonist—NECA (F2,31=
2.247, p=0.1238) and antagonist—caffeine (F2,34=0.4477,
p=0.643).
It was shown in the Tukey test that both doses of CPA
significantly reduced (p<0.01) the conditioning score on the
9th day of the experiment and both doses of DPCPX signifi-
cantly increased the time spent at the morphine-paired com-
partment (p<0.05). Other adenosine ligands did not produce
any significant differences.
Effects of adenosine ligands on the acquisition
of sensitization to CPP in previously conditioned rats
(Fig. 3.)
One-way ANOVA demonstrated significant changes after all
the used adenosine ligands: CPA (F2,33=6.74, p=0.0037),
CGS 21680 (F2,37=7.826, p=0.0016), NECA (F2,38=
8.281, p=0.0011), DPCPX (F2,33=11.49, p=0.0001), SCH
58261 (F2,29=6.22, p=0.0153), and caffeine (F2,35=22.87,
p=0.0001).
In the Tukey test, all the adenosine ligands (agonists and
antagonists) significantly reduced the voluntary rat confine-
ment in the morphine-paired compartment. Significant effects
were observed after the administration of a higher dose of
CPA (0.1 mg/kg)—(p<0.01) and NECA (0.001 mg/kg)—
(p<0.001). Significant changes were also observed after an
application of both doses of CGS 21680 (0.025 and
0.05 mg/kg)—p<0.01 and p<0.05, respectively; DPCPX
(1.0 and 2.0 mg/kg)—p<0.01 and p<0.001, respectively;
SCH 58261 (0.5 and 1.0 mg/kg)—p<0.01 and p<0.05, re-
spectively; and caffeine (5.0 and 10.0 mg/kg)—p<0.001.
Discussion
In the presented experiment, we confirmed that the sensitiza-













Morphine  0.75 for sensitization 
** **
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9th Day - expression  
Morphine 5.0 for conditioning 
Fig. 2 Influence of adenosine agonists and antagonists on the expression
of sensitization to CPP in morphine-conditioned rats. Morphine
sensitization was obtained by administration of priming dose of
morphine (0.75 mg/kg, ip) in morphine-conditioned rats (5 mg/kg, ip).
Adenosine ligands were injected 20 min before the priming dose of
morphine (on 9th day). Results are expressed as mean±S.E.M of scores
(n=9–10 rats/group). One-way ANOVA showed significant changes in
the time spent at the morphine-paired compartment. **p<0.01 vs rats
conditioned with morphine, *p<0.05 vs rats conditioned with morphine































Fig. 3 Influence of adenosine agonists and antagonists on the acquisition
of sensitization to CPP in morphine-conditioned rats. Morphine
sensitization was obtained by administration of priming dose of
morphine (0.75 mg/kg, ip) in morphine-conditioned rats (5 mg/kg, ip).
Adenosine ligands were injected three times, 20 min before each
morphine injection (5.0 mg/kg), on 2nd–4th day. One-way ANOVA
showed significant changes in the time spent at the morphine-paired
compartment. ***p<0.001 vs rats conditioned with morphine,
**p<0.01 vs rats conditioned with morphine, *p<0.05 vs rats
conditioned with morphine (Tukey test); CAFF caffeine, CGS CGS
21680, SCH SCH 58261
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developed in rats which were previously conditioned with
morphine. But the major finding concerns an important role
of the adenosinergic system, both in sensitization expression
and acquisition.
In the first step of the experiments, we confirmed the results
of other authors (Alaei and Hosseini 2007; Sahraei et al. 2007;
Shippenberg et al. 2009). showing that morphine, given at a
dose of 5.0 mg/kg and in a 3-day schedule, produced its re-
warding effect, as expected. Our results are consistent with the
literature data, which demonstrated a rewarding action of mor-
phine at a dose range between 2.0 and 10.0 mg/kg (Leri and
Franklin 2000; Lu et al. 2002; Sahraei et al. 2007). Therefore,
in order to induce sensitization to CPP in rats, which were
previously conditioned with morphine, a low dose of mor-
phine (0.5 and 0.75 mg/kg) was administered after 5-day mor-
phine treatment withdrawal (a method described by Sahraei at
al. 2007). We observed that 0.75 mg/kg of morphine signifi-
cantly increased in voluntary rat confinement periods at a
morphine-paired compartment, which confirmed that sensiti-
zation to CPP was developed in the studied animals, while
there was no such effect in the rats, treated with 0.5 mg/kg
of morphine. Therefore, the dose of 0.75 mg/kg of morphine
was used in further experiments, studying morphine-induced
sensitization to CPP in previously morphine-conditioned rats.
Second, an involvement of the adenosinergic system was
demonstrated in the morphine-induced sensitization to CPP.
For this purpose, we used various adenosine receptor ligands
(CPA, CGS 21680, NECA, DPCPX, SCH 58261, and caf-
feine), which are commonly used as pharmacological tools
in various experimental protocols. All of them were used at
low, ineffective doses, which was demonstrated in the loco-
motor activity test (see Table 1). These doses are commonly
used in behavioral experiments (Karcz-Kubicha et al. 2003;
Kopf et al. 1999; Munzar et al. 2002; Salem and Hope 1997).
We demonstrated that adenosine A1 receptors played an
important role in the expression of the morphine-induced sen-
sitization to CPP because A1 agonist—CPA—significantly
reduced, while A1 antagonist—DPCPX—markedly increased
the time, spent by rats at the preferred compartment. These
results are in agreement with the results of other authors from
their studied behavioral sensitization (Hobson et al. 2012;
Knapp et al. 2001; Listos et al. 2011; Shimazoe et al. 2000).
The adenosine A2A receptors seem to be less important in
expression of the sensitization to CPP in morphine-
conditioned rats because CGS 21680 and SCH 58261 did
not induce any significant effects in the studied rats.
However, their role should not be completely excluded. In
case of a higher dose of CGS 21680 and a lower dose of
SCH 58261, the results were close to the statistical signifi-
cance. Other authors demonstrated an inhibitory activity of
A2A receptors in the expression of behavioral sensitization in
different models (Filip et al. 2006; Hobson et al. 2012; Knapp
et al. 2001; Shimazoe et al. 2000). but those experiments were
focused on sensitization to cocaine and methamphetamine.
There are no literature data to show the effects of adenosine
A2A receptors in morphine sensitization expression. The
mechanism of action of cocaine or methamphetamine is dif-
ferent from that of morphine, which may explain the behav-
ioral discrepancies between the effects of A2A receptors in
cocaine/methamphetamine and morphine sensitization
models. Interestingly enough, a simultaneous stimulation or
blockade of both A1 and A2A adenosine receptors by NECA
or caffeine, respectively, did not induce any effect in the stud-
ied rats, either. Lack of the effect after administration of
NECA and caffeine in the expression of sensitization to CPP
in morphine-conditioned rats seems to be associated with in-
teractions between adenosine receptors. Cunha et al. (1994)
described an interaction between A1 and A2A receptors.
Table 1 Effects of morphine and
adenosine ligands on locomotor
activity of rats
Locomotor activity of animals
(Mean distance travelled [m])
Drug Acute dose Drug combinations
Saline 24.15±2.3 Morphine 0.5 in sensitized rats 25.87±2.1
Morphine 0.5 22.38±3.7 Morphine 0.75 in sensitized rats 26.36±3.1
Morphine 0.75 25.05±1.6 CPA 0.1+morphine 0.75 in sensitized rats 23.98±3.6
Morphine 5.0 27.32±4.0 CGS 0.05+morphine 0.75 in sensitized rats 24.16±4.2
CPA 0.1 22.11±2.3 NECA 0.001+morphine 0.75 in sensitized rats 26.74±2.9
CGS 0.05 21.15±3.1 DPCPX 2.0+morphine 0.75 in sensitized rats 27.17±4.3
NECA 0.001 22.02±4.0 SCH 1.0+morphine 0.75 in sensitized rats 29.79±3.1
DPCPX 2.0 27.87±3.2 CAFF 10.0+morphine 0.75 in sensitized rats 29.87±2.1
SCH 1.0 29.87±2.6
CAFF 10.0 30.77±3.2
There were not observed any alters in locomotor activity of rats after administration of all doses of morphine,
adenosine ligands, and their combination
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According to that, in some circumstances (high frequency
stimulation), A2A receptors are able to decrease the activity
of A1 receptors. A few reports also document the existence of
interactions between adenosine A2B/A3 and A1 receptors. The
administration of selective adenosine A2B agonist (BAY 60-
6583) attenuated the activity of DPCPX (Gonçalves et al.
2015). and A3 receptor activation reduced the inhibitory ac-
tion of adenosine A1 receptors in the hippocampus
(Dunwiddie et al. 1997). Sebastiao and Ribeiro (2009) pre-
cisely described that phospholipase C-coupled response of
metabotropic A2A, A2B, and A3 receptors may be involved
in inhibition of presynaptic A1 receptors in nerve terminals.
As literature data report, DPCPX has an affinity mainly for A1
receptors but it may also act on A2B receptors (Fredholm et al.
2001, 2011). While NECA, as non-selective adenosine recep-
tor agonist, is able to produce the effects mainly by stimulation
of A1 and A2A receptors but also by A2B and A3 receptors
(Volpini et al. 2003; Fredholm et al. 2011). In our experiments,
we used low doses of all adenosine compounds, and involve-
ment of adenosine A2B and A3 receptors seems to be insignif-
icant for the obtained results; however, the lack effect of
NECA inmorphine expressionmay be explaind by interaction
between adenosine receptors.
Furthermore, the effect of adenosine ligands in the acqui-
sition of sensitization to CPP in rats was a fairly interesting
observation. All the adenosine ligands, administered on the
2nd–the 4th day, significantly inhibited the acquisition of sen-
sitization to CPP in rats. The inhibitory effect of all adenosine
ligands in acquisition is intriguing, but not surprising. There
are scientific reports, showing a similar pattern of the ligands’
activity. For example, A1 agonists and antagonists are able to
reduce hyperalgesia, or A2A agonists and antagonists decrease
neuronal death by reducing of neurotransmitter release (for
ref. see Stone et al. 2009). We suppose that physiological
relationships between adenosine and dopamine receptors in-
fluence glutamate release from the presynaptic terminals,
where A1 and A2A receptors are also strongly expressed. It is
worth noting that other authors demonstrated some attenua-
tion of nicotine- (Castañé et al. 2006). amphetamine- (Bastia
et al. 2005). and cocaine- (Soria et al. 2006) induced reward-
ing effects in mice with lacking A2A receptors. Weisberg and
Kaplan (1999) demonstrated that A1 antagonist attenuated the
development of morphine sensitization. On the other hand,
Brown et al. (2009) showed that A2A receptor was not neces-
sary for the development of morphine sensitization.
The participation of adenosinergic system in behavioral
sensitization has been already described in our previous pa-
pers. Then, we showed that CPA, CGS 21680, and NECA
were able to inhibit the acquisition of morphine-seeking be-
havior in mice, observed as the sensitization to the locomotor
activity (Listos et al. 2011). In another one, CGS 21680 and
NECA, but not CPA, reduced the hypersensitivity to acute
dose of morphine administered during morphine withdrawal
period (Listos et al. 2008). Thus, both papers presented the
beneficial role of adenosine receptor agonists in various tests
reflected the relapse to drug use. At present, in rats, we signif-
icantly extend this knowledge, because the effect of adenosine
agonists and antagonists was studied in, both, expression and
acquisition of sensitization to CPP. This test reflected the sen-
sitization to morphine rewarding effect. In this context, the
participation of adenosinergic system was examined for the
first time. In all these studies, we comprehensively showed an
important role of adenosinergic system in various aspects of
morphine sensitization.
Considering potential mechanisms, which may underlie the
obtained results, several options should be taken into account.
First, the distribution of adenosine A1 and A2A receptors in the
central nervous system and their adaptive changes after chron-
ic opioid treatment should become subject of analysis.
Physiologically, A1 receptors are abundant in the whole brain,
while A2A receptors are located mainly on striatopallidal γ-
aminobutyric acid (GABA)ergic neurons, in the olfactory
bulb and the hippocampus. The activity of A1 receptors is
associated with the reduced release of different neurotransmit-
ters in the central nervous system and, in this way, with sup-
pressing neuronal activity in the brain (Sebastiao and Ribeiro
2009). while A2A receptors are involved in various interac-
tions with other receptors, such as glutamatergic, dopamine
D2, or cannabinoid CB1 receptors (for ref. see Sebastiao and
Ribeiro 2009). However, after chronic morphine treatment,
some adaptive changes may develop, mainly in adenosine
A1 receptors. For example, a significant increase was ob-
served in the number of A1 receptors (Kaplan et al. 1994). in
the amount of adenosine transporters (Kaplan and Leite-
Morris 1997) and in adenosine sensitivity in nucleus accum-
bens (Brundege andWilliams 2002). On the contrary, a chron-
ic opioid treatment does not seem to affect the A2A receptor
level because the number of A2A receptors in the striatum
remained unaltered after a chronic morphine treatment in mice
(Kaplan et al. 1994).
Second, apart from the neuroadaptive changes in the
adenosinergic system, other mechanisms seem to be en-
gaged. Several findings demonstrate that, during
morphine-induced sensitization, alterations in dopaminer-
gic and glutamatergic receptors may occur within some
brain areas (ventral tegmental area, nucleus accumbens,
prefrontal cor tex, amygdala , and hippocampus)
(Robinson and Berridge 2008; Vanderschuren and
Kalivas 2000; Vanderschuren and Pierce 2010; Wolf
2003). The expression of sensitization is associated with
increased extracellular dopamine levels, the supersensitiv-
ity of D1 receptors in the striatum (Tjon et al. 1994,
1997). and elevated dopamine levels in nucleus accum-
bens (Ka l iva s and Duffy 1987 ; Spanage l and
Shippenberg 1993; Spanagel et al. 1993) in sensitized
animals. Otherwise, the development of morphine-
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induced sensitization is more related to the glutamatergic
system and the ventral tegmental area; the antagonists of
both types of glutamate receptors—NMDA (MK-801 and
CGS 19755) and AMPA (LY293558)—were able to pre-
vent the morphine sensitization process (Jeziorski et al.
1994; Carlezon et al. 1999, respectively). It is likely that
the neuroadaptive changes in dopamine receptors
(express ion) as wel l as in glu tamate receptors
(acquisition) could have affected the results in our study,
especially that both dopamine and glutamate receptors are
closely linked to adenosine receptors and the interactions
between dopamine–adenosine receptors and glutamate–
adenosine receptors (for ref. see Fredholm 2001;
Sebastião and Ribeiro 2009) are well described.
Considering all the connections between adenosine and
other receptors in the central nervous system, it may be
suggested that the involvement of A1 ligands in the expres-
sion of sensitization to CPP might have been associated
with a morphine-induced increase in the number of aden-
osine A1 receptors and in a more expressed effect on D1
receptors. On the other hand, the inhibitory effect of both
adenosine agonists and antagonists in the acquisition of
sensitization to CPP seems to be associated with
neuroadaptive changes within the glutamatergic system,
the role of which in behavioral sensitization is undisputed
(Vanderschuren and Kalivas 2000; Vanderschuren and
Pierce 2010).
In conclusion, behavioral sensitization is a major charac-
teristic of drug addiction and could be used to study the effects
of addictive, abused drugs. In humans, drug-seeking behav-
iors are strongly manifested even after long-term cessation
periods and are responsible for drug relapse. It is, therefore,
extremely important to explore all the mechanisms associated
with sensitization. In the presented findings, the sensitization
to the CPP was confirmed in rats, after the priming dose of
morphine, the rats having previously been conditioned with
morphine. We also observed that adenosine A1 receptor
played an important role in the expression of the morphine-
induced sensitization to CPP. Finally, we indicated that both
stimulation and blockade of A1 and/or A2A receptors inhibited
the acquisition of the morphine-induced sensitization to CPP
in rats. The obtained results strongly support the significance
of the adenosinergic system, both in the expression and acqui-
sition of sensitization to CPP. They seem to be important for
the identification of connections in the central nervous system
which can help finding new strategies to attenuate rewarding
action of morphine.
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